Mulmit

Celldex Therapeutics, Inc.Celldex Therapeutics, Inc.

CLDX Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-311,545,000-287,367,000-258,757,000-3.9
2024-12-317,020,000-195,078,000-157,863,000-2.45
2023-12-316,883,000-154,542,000-141,429,000-2.92
2022-12-312,357,000-115,234,000-112,325,000-2.4
2021-12-314,651,000-71,243,000-70,511,000-1.64

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-06-25Lawver Teri LSVP & Chief Commercial Officer90,000
2026-06-25Jimenez Freddy A.SVP & GENERAL COUNSEL93,000
2026-06-25Torres Denice26,000
2026-06-25Heath-Chiozzi MargoSVP OF REGULATORY AFFAIRS95,000
2026-06-25Cavanaugh SarahSVP OF CORP AFFAIRS & ADMIN.95,000
2026-06-25Martin Samuel BatesSVP AND CFO93,000
2026-06-25Jain Rita26,000
2026-06-25Crowley ElizabethSR. VP & CPDO100,000
2026-06-25Young Diane C.SVP, CHIEF MEDICAL OFFICER57,000
2026-06-25NEIL GARRY ARTHUR26,000
2026-06-25Cohen Cheryl26,000
2026-06-25Brownlie Keith L26,000

8-K events

FiledItems
2026-08-06Results of operations · Financial statements and exhibits
2026-07-15Officer or director change · Financial statements and exhibits
2026-06-26Officer or director change · Submission of matters to a vote · Financial statements and exhibits
2026-05-07Results of operations · Financial statements and exhibits
2026-04-02Entry into a material agreement · Other events · Financial statements and exhibits
2026-02-25Results of operations · Financial statements and exhibits
2025-11-10Results of operations · Financial statements and exhibits
2025-08-19Other events · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

In Vitro & In Vivo Diagnostic Substances — 같은 업종, 그리고 규모가 비슷한 기업In Vitro & In Vivo Diagnostic Substances — and other companies of a similar size

SEC가 같은 업종(In Vitro & In Vivo Diagnostic Substances)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (In Vitro & In Vivo Diagnostic Substances) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.